SLC6A3 and Parkinson disease: Nevertheless, DAT-SPECT can be an excellent tool to map the spatial and temporal patterns of dopaminergic dysfunction in PD, providing evidence of a negative exponential loss of dopaminergic cells in early disease, which slows down with increasing symptom duration [72].